Home Newsfeeds Jefferies Downgrades IronNet to Underperform, Lowers Price Target to $1

Jefferies Downgrades IronNet to Underperform, Lowers Price Target to $1

Jefferies analyst Joseph Gallo downgrades IronNet (NYSE:IRNT) from Hold to Underperform and lowers the price target from $2.25 to $1.

byBenzinga Newsdesk

September 15, 2022

1 minute read

Jefferies analyst Joseph Gallo downgrades IronNet (NYSE:IRNT) from Hold to Underperform and lowers the price target from $2.25 to $1.

‘Dogecoin Killer’ Shiba Inu Burn Rate Skyrockets Over 4200% After New Plan To Automate Burn Processes Unveiled

By Mehab Qureshi

January 25, 3:11 AM

Self-proclaimed ‘Dogecoin (CRYPTO: DOGE) killer' Shiba Inu (CRYPTO: SHIB), has witnessed a surge in token burn activity with an increase exceeding 4,200% within a 24-hour window.

$BONE

M&A
News

Aspen Global To Acquire The Entire Share Capital Of Its Subsidiary, Sandoz (China) Pharmaceutical Co. With Commercialization Rights And Related Intellectual Property For A Portfolio Of Established Products

By Charles Gross

December 4, 7:10 AM

Aspen Pharmacare Holdings Limited, a global multinational specialty pharmaceutical company, has announced that Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has

NVS

Equitrans Midstream Q4 EPS $0.13, Inline, Sales $355.24M Beat $342.09M Estimate

By Bill Haddad

February 21, 7:33 AM

Equitrans Midstream (NYSE:ETRN) reported quarterly earnings of $0.13 per share which met the analyst consensus estimate. This is a 285.71 percent increase over losses of $(0.07) per share from the same period last year.

ETRN

Cybin Shares Q2 Financial & Business Results, Focus On Licensing Deals For Preclinical Assets

By Lara Goldstein

November 15, 4:13 PM

Cybin Inc. (NYSE: CYBN) reported its unaudited financial results for its second quarter ended September 30, 2022, and provided business highlights for the period.

CYBN

Jefferies Downgrades IronNet to Underperform, Lowers Price Target to $1

Related Posts

‘Dogecoin Killer’ Shiba Inu Burn Rate Skyrockets Over 4200% After New Plan To Automate Burn Processes Unveiled

Aspen Global To Acquire The Entire Share Capital Of Its Subsidiary, Sandoz (China) Pharmaceutical Co. With Commercialization Rights And Related Intellectual Property For A Portfolio Of Established Products

Equitrans Midstream Q4 EPS $0.13, Inline, Sales $355.24M Beat $342.09M Estimate

Cybin Shares Q2 Financial & Business Results, Focus On Licensing Deals For Preclinical Assets